Fresenius Medical Care AG (FMS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 2B 4B 6B FY13: 5B FY14: 5.3B FY13 FY14

Gross Profit Annual

0 2B 4B 6B FY07: 3.4B FY08: 3.6B FY09: 3.8B FY10: 3.8B FY11: 4.2B FY12: 4.6B FY13: 4.7B FY14: 5B FY15: 5.3B FY16: 5.8B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16

Operating Income Annual

0 900M 1.8B 2.7B FY07: 1.6B FY08: 1.7B FY09: 1.8B FY10: 1.9B FY11: 2.1B FY12: 2.2B FY13: 2.3B FY14: 2.3B FY15: 2.3B FY16: 2.6B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16

Net Income Annual

0 500M 1B 1.5B FY07: 717.1M FY08: 817.6M FY09: 891.1M FY10: 978.5M FY11: 1.1B FY12: 1.2B FY13: 1.1B FY14: 1B FY15: 1B FY16: 1.2B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16

Cost of Revenue Annual

0 5B 10B 15B FY07: 6.4B FY08: 7B FY09: 7.4B FY10: 8B FY11: 8.4B FY12: 9.2B FY13: 9.9B FY14: 10.8B FY15: 11.4B FY16: 12.1B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16

Operating Cash Flow Annual

0 800M 1.6B 2.4B FY07: 1.2B FY08: 1B FY09: 1.3B FY10: 1.4B FY11: 1.4B FY12: 2B FY13: 2B FY14: 1.9B FY15: 2B FY16: 2.1B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16

Free Cash Flow Annual

0 500M 1B 1.5B FY07: 626.9M FY08: 329M FY09: 765M FY10: 844.5M FY11: 848.6M FY12: 1.4B FY13: 1.3B FY14: 929.8M FY15: 1B FY16: 1.1B FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 150M 300M 450M FY16: 306.3M FY17: 306.6M FY18: 306.5M FY19: 302.7M FY20: 294.1M FY21: 292.9M FY22: 293.2M FY23: 293.4M FY24: 293.4M FY25: 291.2M FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.50 3.00 4.50 Q4 '08: 2.74 Q1 '09: 2.77 Q2 '09: 2.80 Q3 '09: 2.87 Q4 '09: 2.99 Q1 '10: 3.03 Q2 '10: 3.11 Q3 '10: 3.17 Q4 '10: 3.23 Q1 '11: 3.26 Q2 '11: 3.30 Q3 '11: 3.40 Q4 '11: 3.52 Q1 '12: 4.00 Q2 '12: 4.08 Q3 '12: 4.04 Q4 '12: 3.87 Q1 '13: 3.40 Q2 '13: 3.32 Q3 '13: 3.35 Q4 '13: 3.66 Q1 '14: 3.60 Q2 '14: 3.51 Q3 '14: 3.49 Q4 '14: 3.44 Q1 '15: 3.45 Q2 '15: 3.47 Q3 '15: 3.44 Q4 '15: 3.38 Q1 '16: 3.44 Q1 '09 Q1 '10 Q1 '11 Q1 '12 Q1 '13 Q1 '14 Q1 '15 Q1 '16

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.